Related by context. All words. (Click for frequent words.) 71 LHRH antagonists 71 CYT# potent vascular disrupting 70 ribonucleotide reductase clinically validated 70 Blinatumomab 70 dasatinib Sprycel 70 Smac mimetics 70 M2 subunit 69 erlotinib Tarceva ® 69 receptor tyrosine kinase inhibitor 69 NS5b 69 IAP inhibitor 69 imatinib Gleevec ® 69 bevacizumab Avastin ® 69 mTOR mammalian target 68 vinca alkaloid 68 essential thrombocythemia ET 68 myelofibrosis polycythemia vera 68 Epidermal Growth Factor Receptor 68 Anthracyclines 67 gastro intestinal inflammation 67 systemic fungal infections 67 chemically modified siRNA 67 NS5B polymerase 67 dasatinib Sprycel ® 67 GW# [003] 67 IAP inhibitors 66 Immunotherapeutic 66 Daclizumab 66 pertuzumab 66 PKC# 66 IMiDs ® 66 antimetabolite 66 Pertuzumab 66 metastatic colorectal 66 polymerase inhibitors 66 nucleoside analog 66 IMiDs R 66 trastuzumab Herceptin R 66 Protease inhibitors 66 TLR9 agonist 66 Factor Receptor 66 Sezary syndrome 66 novel immunomodulatory 66 orally administered inhibitor 66 Anthracycline 66 IMiDs ® compound 66 myelodysplastic myeloproliferative diseases 66 antibody MAb 66 ovarian breast 66 chronic eosinophilic leukemia 66 novel immunotherapies 66 MAGE A3 ASCI 66 non alcoholic steatohepatitis 66 targeted radiotherapeutic 65 infliximab Remicade 65 hypereosinophilic syndrome 65 kidney urologic 65 Aflibercept 65 aflibercept VEGF Trap 65 multi kinase inhibitor 65 MKC# MT 65 oncologic diseases 65 alpha folate receptor 65 OMP #R# 65 Personalized Immunotherapy 65 protease inhibitors PIs 65 inhibit replication 65 LHRH receptor positive 65 neovascular diseases 65 molecularly targeted 65 neuroendocrine cancers 65 sirtuin inhibitor program 65 diseases fat malabsorption 65 investigational monoclonal antibody 65 BRAF inhibitor 65 Sapacitabine 65 sorafenib Nexavar 65 EGFR inhibitors 65 histone deacetylase HDAC inhibitors 65 ALN PCS 65 oral prodrug 65 Solazed TM 65 FUSILEV enhances 65 antimitotic 65 Sudhir Agrawal D.Phil 65 sorafenib tablets 65 selective kinase inhibitor 65 PLX MS 65 recurrent glioblastoma multiforme 65 Talabostat 64 Annamycin 64 Enkephalin 64 metastatic renal 64 chemotherapy hormonal therapy 64 chronic myeloid 64 alkylating 64 multiple sclerosis psoriasis 64 immune modulating 64 Protein Kinase C 64 LymphoStat B belimumab 64 PNP inhibitor 64 infectious diseases autoimmune diseases 64 HMG CoA reductase inhibitors 64 nucleoside reverse transcriptase inhibitor 64 c MET 64 irinotecan oxaliplatin 64 anti PlGF 64 Complicated Skin 64 Vidaza azacitidine 64 MTP inhibitor 64 refractory metastatic 64 multitargeted 64 Panzem R 64 antisense inhibitors 64 thetreatment 64 liposomal formulation 64 ADP receptor antagonist 64 mTOR kinase 64 investigational humanized monoclonal antibody 64 Deforolimus 64 Lymphocytic 64 R Saizen R 64 HBeAg negative 64 K ras mutations 64 pan HDAC inhibitor 64 RNAi therapeutic targeting 64 HuLuc# 64 adalimumab Humira 64 systemic RNAi therapeutic 64 commercialize deforolimus 64 chimeric monoclonal antibody 64 Philadelphia Chromosome Positive 64 sorafenib Nexavar R 64 PI3K/mTOR 64 Provectus Pharmaceuticals specializes 64 protein kinase inhibitors 64 selective modulator 64 Thiovir 64 Zolinza 64 Epstein Barr Virus EBV 64 lymphoid malignancies 64 hemorrhagic fever viruses 64 humanized monoclonal 64 Maribavir 64 Squalamine 64 reverse transcriptase inhibitors 64 peripherally acting 64 HCV NS5B polymerase 64 agent VDA 64 Tumor Necrosis Factor 64 thalidomide Thalomid 64 acetonide FA 64 trastuzumab Herceptin ® 64 Naive Patients 64 cetuximab Erbitux R 64 targeting PCSK9 64 LHRH analogues 64 treating neuropathic pain 64 Human papillomavirus 64 vWD 64 HSP# inhibitor 64 imatinib Gleevec 64 proteasome inhibitors 64 epigenetic therapies 64 tyrosine kinase inhibitor 64 cardio metabolic diseases 64 HCV protease inhibitors 64 NS#/#A protease 64 RhuDex ® 64 oncolytic 63 FOLOTYN ® 63 hyperplasia BPH 63 protein kinase inhibitor 63 MEK inhibitors 63 bladder ovarian 63 DCVax R 63 inhibits Akt activation 63 Mitomycin C 63 FGFR 63 Elotuzumab 63 IMA# 63 colorectal bladder 63 cMET 63 CCR5 receptor antagonist 63 hematological malignancy 63 virotherapy 63 Temsirolimus 63 signal transduction inhibitor 63 GMX# 63 targeting CD# 63 Enzastaurin 63 humanised monoclonal antibody 63 myeloproliferative disorders 63 Aurora Kinase 63 EGFR tyrosine kinase inhibitors 63 AAG geldanamycin analog 63 agonists antagonists 63 novel VDA molecule 63 immunotherapeutic vaccine 63 IMC A# 63 pathophysiological effects 63 ® lenalidomide 63 JAK#/JAK# 63 SERMs 63 PI3 Kinase 63 Fludara ® 63 Aviptadil 63 Entry Inhibitor 63 gastrointestinal stromal tumors GIST 63 Tyrima 63 Interferon beta 63 monoclonal antibody MAb 63 radezolid 63 polycythemia vera essential thrombocythemia 63 Cloretazine 63 leukemia multiple myeloma 63 CTAP# Capsules 63 metastatic bladder 63 MDS MPD 63 Amgen Neulasta R 63 HIV integrase inhibitors 63 investigational therapies 63 candidates Azedra TM 63 nilotinib Tasigna ® 63 castrate resistant 63 Antitumor Activity 63 EGFR pathway 63 castrate resistant prostate cancer 63 5 fluorouracil leucovorin 63 Epstein Barr virus EBV 63 anti angiogenic agents 63 protein tyrosine phosphatase 1B 63 Vidaza ® 63 mda 7 63 vaginal candidiasis 63 idarubicin 63 IMC #B 63 microtubule inhibitor 63 Familial Adenomatous Polyposis FAP 63 Mitoxantrone 63 CCR5 antagonist 63 anticancer antiviral 63 TLR8 agonist 63 included exfoliative dermatitis 63 relapsed leukemia 63 p# inhibitor 63 Epothilones 63 Elvitegravir 63 Bavituximab 63 novel peptide 63 TNF Blockers 63 constipation OIC 63 FLT3 63 immunomodulators 63 metaglidasen 63 BRAF mutant 63 thiazolides 63 anticancer therapies 63 mycosis fungoides 63 EGFr expressing metastatic colorectal 63 hepatitis C HCV 63 invasive candidiasis 63 relapsed ovarian cancer 63 selectively inhibit 63 nucleotide analogue 63 cardio renal 63 Surgical resection 63 evaluating picoplatin 63 non nucleoside inhibitor 63 delta gamma agonist 63 haematological malignancies 63 inherited metabolic disorders 63 NTDDS 63 cytoprotective 63 delivered RNAi therapeutic 63 IgG1 monoclonal antibody 63 docetaxel Taxotere ® 63 nucleoside analogues 63 CYP#A# CYP#D# 63 neuro inflammatory 63 Archexin 63 systemic autoimmune 63 Relapsed Refractory 63 selective inhibition 63 endocrine therapies 63 metastatic malignant melanoma 63 OMP #M# 63 Kinoid 63 Denufosol 63 dose intramuscular 63 TRO# 63 Eculizumab 63 isoform selective 63 antisense therapies 63 atypical hemolytic uremic syndrome 63 hormone LHRH antagonist 63 NS4A 63 systemic antifungal 63 cyclophilin inhibitors 62 gemcitabine Gemzar 62 investigational immunotherapy 62 RNA antagonists 62 Factor VIIa 62 sapacitabine CYC# 62 Systemic lupus erythematosus SLE 62 inhaled bronchodilators 62 Myelofibrosis 62 MyVax R 62 targeted antifolate 62 histone deacetylase HDAC 62 glioblastoma multiforme GBM 62 relapsed MM 62 basal cell carcinoma BCC 62 itraconazole Sporanox 62 antibody MT# 62 meropenem 62 cyclin dependent kinase inhibitor 62 endothelin receptor antagonists 62 cell carcinoma RCC 62 Omacetaxine 62 oropharyngeal candidiasis OPC 62 immunomodulator 62 alkylating agent 62 IGF IR 62 biodefense pathogens 62 Kinase Inhibitor 62 immunomodulating 62 potent antiproliferative 62 chemokine receptor 62 Pharmacokinetics PK 62 subependymal giant cell 62 MDS AML 62 epithelial tumors 62 antiproliferative effects 62 gefitinib Iressa 62 JAK1 62 Methylnaltrexone 62 NMDA antagonists 62 Janus kinase 62 PORxin TM 62 paclitaxel Taxol 62 ASG 5ME 62 Panzem R NCD 62 AEG# 62 TNF Tumor Necrosis Factor 62 therapies ACTs 62 vinca alkaloids 62 RhuDex R 62 GRNOPC1 contains 62 GRN# 62 prokinetic agent 62 irreversible inhibitor 62 JAK2 inhibitor 62 Imatinib mesylate 62 sodium glucose cotransporter 62 refractory chronic lymphocytic 62 Kinase inhibitors 62 Viprovex TM 62 HER2 positive metastatic breast 62 IMiDs 62 psoriasis rheumatoid arthritis 62 interleukin IL -# 62 CEQ# 62 nonmetastatic 62 siRNA therapeutic 62 inflammatory autoimmune 62 thromboembolic disease 62 Monoclonal antibody 62 Leukemias 62 selectively inhibited 62 Gleevec resistant 62 Cutaneous T 62 oral dual endothelin 62 Combivir Kivexa 62 monoclonal antibody IgG1 Mab 62 nonnucleoside reverse transcriptase inhibitors 62 unresectable tumors 62 Cytomegalovirus CMV 62 Oracea TM 62 hormone gastrin 62 humanized monoclonal antibody 62 etanercept Enbrel 62 taxane chemotherapy 62 ovarian endometrial 62 JAK inhibitors 62 cholesteryl ester transfer 62 dermatologic diseases 62 eIF 4E 62 immunotoxin 62 HCV polymerase inhibitors 62 tigecycline 62 cell lymphoma CTCL 62 trastuzumab Herceptin 62 Peginterferon alfa 2b 62 Gleevec imatinib mesylate 62 dihydrochloride Tablets 62 Alfacell proprietary ribonuclease 62 histologies 62 Golimumab 62 Achieves Primary Endpoint 62 HCV polymerase 62 pancreatic colon 62 Nitazoxanide 62 Hsp# inhibition 62 immunotherapeutic 62 nucleoside analogue 62 HER1 62 Carfilzomib 62 kinase inhibition 62 lipoglycopeptide 62 Angiotensin II 62 LRP5 62 ganetespib 62 Carcinoid tumors 62 FGFR1 62 docetaxel Taxotere R 62 VEGF receptors 62 metastatic gastric 62 subcutaneous immunoglobulin 62 hormone refractory metastatic prostate 62 direct thrombin inhibitors 62 Glioblastoma multiforme GBM 62 galiximab 62 ovarian prostate 62 soluble tumor necrosis 62 XL# XL# 62 MCSP respectively 62 immune modulators 62 posterior uveitis 62 lenalidomide Revlimid R 62 grade cervical intraepithelial 62 Sphingomab TM 62 Alzheimer disease cognitive impairment 62 histone deacetylases 62 indinavir Crixivan 62 Chemokine Receptor 62 Granulocyte Colony Stimulating Factor 62 Exelixis XL# 62 antithrombotics 62 decompensated liver disease 62 reversible inhibitor 62 secondary hyperparathyroidism 62 RhuDex TM 62 metastatic carcinoid 62 HDAC enzymes 62 Vandetanib 62 TTR amyloidosis 62 rheumatoid arthritis inflammatory bowel 62 radiation chemoradiation 62 Prostacyclin 62 protease inhibitor PI 62 Romidepsin 62 abnormal p# 62 Seliciclib 62 non peptidic protease 62 metastatic androgen independent 62 pralatrexate injection folate analogue 62 pelvic malignancies 62 effector function 62 nucleoside reverse transcriptase inhibitors 62 Nexavar sorafenib 62 alfa 2a 62 BCG refractory carcinoma 62 C1 INH deficiency 62 small molecule thrombopoietin 62 selective antagonist 62 benign prostatic hypertrophy BPH 62 HER2 overexpression 62 xenograft models 62 FOLFOX6 chemotherapy regimen 62 Plaquenil 62 orally inhaled migraine 62 Phase #b/#a clinical 62 echinocandin 62 Inhaled nitric oxide 62 thromboxane A2 61 antiangiogenesis 61 applying Lipid Sciences 61 proteasome inhibitor 61 delta isoform 61 NEUGENE 61 Recombinant interferon alpha 61 Cardiotoxicity 61 lintuzumab SGN 61 TNF blocking 61 cetuximab Erbitux ® 61 histone deacetylase inhibitor 61 BCR ABL inhibitors 61 myeloproliferative diseases 61 mTOR inhibitors 61 accumulate preferentially 61 Glucocorticoids 61 Kinases 61 Homspera TM 61 modulates Akt 61 INSPIRE Trial Phase III 61 dexamethasone Decadron 61 DNA methyltransferase inhibitors 61 ALN TTR 61 chronic constipation CC 61 triggers apoptosis programmed 61 VEGF inhibitors 61 demonstrated antitumor activity 61 ASONEP TM 61 RAF kinase 61 compound AEZS 61 THR beta agonist 61 EGFR TKI 61 leukotriene pathway 61 cytomegalovirus CMV 61 HQK 61 cyclophosphamide chemotherapy 61 chemopreventive agents 61 gastrointestinal stromal tumors GISTs 61 inhaled TPI ASM8 61 angiogenesis inhibition 61 Akt inhibitor 61 systemic juvenile idiopathic 61 immunotherapeutics 61 TroVax ® 61 Pafuramidine 61 Atripla combines 61 CTAP# 61 vidofludimus 61 immunomodulatory 61 AT1R 61 uric acid lowering 61 PEGylated anti 61 oral ghrelin agonist 61 Ceflatonin 61 JAK2 enzyme 61 Hepatitis C Virus HCV 61 CEA CD# Her2 61 Oragens R 61 5 HT2A serotonin 61 Anidulafungin 61 colorectal lung 61 prescribed proton pump 61 Alferon LDO 61 Noxafil 61 engineered RAP peptides 61 lapatinib Tykerb 61 SNT MC# 61 gastrointestinal mucositis 61 cervical intraepithelial neoplasia 61 TRAIL receptor antibodies 61 metastatic malignant 61 IL# PE#QQR 61 HGS ETR2 61 Acute Exacerbations 61 treat chronic sinusitis 61 PARP inhibitor 61 Zalypsis 61 Oncolytic 61 mediated apoptosis 61 M# rationally 61 Abiraterone acetate 61 Cyclooxygenase 2 61 cutaneous T 61 VitiGam 61 multiple sclerosis rheumatoid arthritis 61 anticancer therapeutics 61 R sorafenib tablets 61 cytostatic 61 Irinotecan 61 denileukin diftitox 61 erythematosus 61 artemisinin derivative 61 ATRA IV 61 PI3K/Akt pathway inhibitor 61 Myelodysplastic syndromes MDS 61 virus HCV protease inhibitor 61 Evoltra ® 61 Belimumab 61 Pathway Inhibitor 61 infectious diseases autoimmune 61 DFMO 61 cytotoxics 61 immunotherapeutic approaches 61 systemic anaplastic large 61 Locked Nucleic Acid LNA 61 CRTH2 61 Associated Adipose Redistribution 61 JAK3 61 inhibit EGFR 61 immunologic diseases 61 hormone refractory 61 polycythemia vera PV 61 Flt3 61 hypoxia activated prodrug 61 Cetrorelix 61 antisense oligonucleotides 61 grade cervical dysplasia 61 oncolytic vaccine 61 Pralatrexate 61 neuropathic pain metabolic diseases 61 Viprovex R 61 SPRYCEL ® 61 inhibit vascular endothelial 61 humanized monoclonal antibodies 61 Dendreon investigational 61 chlamydial 61 antiangiogenesis therapies 61 EGFR HER2 61 entinostat 61 CCR9 antagonist 61 CFTR corrector 61 Angiotensin converting enzyme 61 Notch receptors 61 class mGluR5 inhibitor 61 Nanobody 61 anti mitotic 61 Panzem NCD 61 potent cytotoxic 61 Ribavirin causes 61 immunosuppressed patients 61 Symadex 61 tyrosine kinase inhibitors 61 oncogenesis 61 regorafenib 61 immunological diseases 61 reversible inhibitors 61 active cellular immunotherapies 61 Combination therapy 61 hedgehog pathway 61 ALK inhibitors 61 5 HT4 61 CYP#A# substrate 61 HDAC EGFR 61 collagen vascular 61 A3 adenosine receptor 61 Anti angiogenic 61 tubulin binding 61 Hypoxia Inducible Factor 61 targeting miR 61 phosphoinositide 3 61 vascular disrupting agents 61 Therapeutic Vaccine 61 investigational hepatitis C 61 Olaparib 61 G Protein Coupled 61 oncolytic virus therapies 61 BRAF kinase 61 retaspimycin 61 cisplatin gemcitabine 61 herpes simplex viruses 61 immunomodulatory properties 61 glucagon receptor 61 metastatic pancreatic 61 luteinizing hormone releasing 61 acid phosphatase PAP 61 Protease inhibitor 61 tyrosine kinase inhibitor TKI 61 calcineurin inhibitors 61 Teriflunomide 61 cathepsins 61 phosphate S1P 61 serine proteases 61 Glucocorticoid 61 tyrosine kinase inhibitors TKIs 61 molecularly targeted therapies 61 antimetabolites 61 Genentech Rituxan 61 Nonsteroidal anti inflammatory 61 histone deacetylase inhibitors 61 MKC# MKC# PP 61 DG# compounds targeting 61 Opportunistic infections 61 beta interferons 61 AKT inhibitor 61 ErbB3 HER3 61 androgen receptor AR 61 YONDELIS R 61 Photodynamic therapy PDT 61 demethylation agents 61 ovarian pancreatic 61 myeloproliferative neoplasms 61 inflammation autoimmune diseases 61 Candida infection 61 relapsed SCLC 61 Nonalcoholic fatty liver 61 selective inhibitor 61 HyACT 61 acadesine 61 Lenalidomide 61 acute leukemias 61 PDGF receptor 61 polymerase inhibitor 61 velafermin 61 enzyme inhibitor 61 factor TNF 61 HCV protease 61 immunomodulatory therapy 61 alefacept 61 novel topoisomerase 61 GI motility disorders 61 Smac mimetic 61 fluoropyrimidine 61 Muraglitazar 60 recurrent NSCLC 60 Vidofludimus 60 ovarian lung 60 non splenectomized 60 prophylactic vaccines 60 Receptors GPCRs 60 anthrax botulism typhoid 60 investigational oral inhibitor 60 riociguat 60 novel anticancer 60 AVASTIN 60 nilotinib Tasigna 60 metastatic neuroendocrine tumors 60 idiopathic thrombocytopenic purpura ITP 60 multidrug resistance 60 osteolytic bone disease 60 immunosuppressive therapies 60 formerly LymphoStat B 60 drug conjugate 60 PDGFR 60 NPC 1C 60 antifibrotic 60 cilengitide 60 intracellular signaling pathways 60 viral subtypes 60 quinolone 60 Pimavanserin 60 mitochondrial toxicity 60 Malignant Glioma 60 Squamous 60 HPV vaccine protects 60 PSN# [001] 60 polyneuropathy HIV DSP 60 secretory diarrhea 60 enzastaurin 60 Therapeutic antibodies 60 Mg Uk 60 Basal Cell 60 aerosolized AAT 60 HGS ETR1 mapatumumab 60 secretory phospholipase A2 60 castration resistant hormone refractory 60 Amgen Neulasta ® 60 selective serotonin 2C receptor 60 Multidrug 60 primary hyperparathyroidism 60 Rheumatoid Arthritis RA 60 calcitonin gene related 60 Shigatoxin producing E. coli 60 ErbB1 60 either acutely decompensated 60 erlotinib Tarceva 60 ELND-#/AZD-# 60 agonistic human 60 familial amyloidotic polyneuropathy FAP 60 superficial bladder cancer 60 Vaccine Candidate 60 combination antiretroviral therapy 60 novel tubulin binding 60 Pazopanib 60 ara C 60 ADAMTS# 60 alvespimycin 60 stable nucleic acid 60 lupus multiple sclerosis 60 refractory Hodgkin 60 severe malignant osteopetrosis 60 paclitaxel Taxol ® 60 Phase IIb clinical trials 60 erythropoietic 60 Paraplatin ® 60 malignant ascites 60 viral hemorrhagic fevers 60 humanized antibody 60 gastric carcinogenesis 60 HBV HCV 60 fusion enhancers 60 platelet aggregation inhibitors 60 echinocandins 60 oral proteasome inhibitor 60 pramlintide metreleptin combination 60 immuno inflammatory diseases 60 ophthalmology oncology 60 Xyfid TM 60 4 PDE4 enzyme 60 C5aR 60 Ad5FGF 4 60 delay bone metastases 60 oral anti arrhythmic 60 uterine ovarian 60 Angiotensin Converting Enzyme 60 Lisofylline 60 Tumour Vascular Disrupting Agent 60 beta 1a 60 LHRH 60 delafloxacin 60 Menopausal hormone therapy 60 pharmacokinetic interactions 60 Pemetrexed 60 HER2 receptor 60 sarcoma melanoma 60 Bleomycin 60 Ph + acute lymphoblastic 60 rxRNA 60 derivatives Radilex TM 60 benzimidazole 60 monoclonal antibody mAb 60 PI3K inhibitors 60 humanized therapeutic 60 multidrug 60 MAGE A3 protein 60 oncolytic viruses 60 SSc 60 Chronic lymphocytic leukemia 60 novel emulsion formulation 60 flavopiridol 60 diarrhea predominant irritable 60 investigational HCV polymerase 60 differentiated thyroid 60 Traficet EN 60 histone deacetylase 60 oral Janus kinase 60 neurotrophic 60 lymphoma leukemia 60 COPEGUS R 60 immunocompetent adults 60 Leukine ® 60 HER pathway 60 lipid lowering therapies 60 hormonally sensitive 60 Pegylated Interferon 60 immuno modulatory 60 HyperAcute 60 immunodeficiency disorders 60 transthyretin TTR mediated amyloidosis 60 dihydrofolate reductase DHFR 60 platform HDL Mimetic 60 Anti Phospholipid Therapy 60 tiapamil 60 VEGF receptor 60 Glioblastoma Multiforme 60 Ixabepilone 60 phosphodiesterase inhibitors 60 alpha interferons 60 Tykerb lapatinib 60 chronic HCV infection 60 CDDO Im 60 YONDELIS 60 TNF alpha antagonist 60 Virulizin ® 60 intravesical instillation 60 antagomirs 60 oral nucleoside analogue 60 poly ADP ribose polymerase 60 telomerase reverse transcriptase 60 pancreatic prostate 60 heparanase 60 PDE# 60 smoldering myeloma 60 post transplant lymphoproliferative 60 cardiotoxic 60 Kit CD# positive 60 dermatology therapies 60 Macrolide 60 Velcade bortezomib 60 inflammatory autoimmune diseases 60 somatostatin analogues 60 anti angiogenic agent 60 rituximab Rituxan 60 adefovir dipivoxil 60 inhibit viral replication 60 MMP inhibitors 60 bortezomib Velcade R 60 5 HT3 antagonist 60 small molecule tyrosine 60 anthracycline taxane 60 psoriasis inflammatory bowel 60 gamma secretase inhibitors 60 e antigen HBeAg 60 Herceptin trastuzumab 60 Tarvacin 60 thrombotic disorders 60 cytomegalovirus infection 60 pulmonary hypertension PH 60 anticancer therapy 60 thymidylate synthase 60 ChronVac C R 60 Camptosar ® 60 OncoVex 60 MEK inhibitor 60 sphingosine 1 60 triple nucleoside regimen 60 Crizotinib 60 BEXXAR Therapeutic Regimen 60 forodesine 60 immunomodulation 60 hematological indications 60 ixabepilone 60 miconazole Lauriad ® 60 oxaliplatin Eloxatin 60 BRCA deficient 60 Navelbine ® 60 small molecule Hedgehog 60 varicella zoster virus VZV 60 cardiometabolic disorders 60 novel RNAi therapeutics 60 antiangiogenic therapy 60 synthetic retinoid 60 tenofovir Viread 60 gastrointestinal stromal 60 endothelin receptor 60 Aurora kinase 60 potent inhibition 60 CYC# 60 prostaglandin D2 60 insulin sensitizers 60 selective estrogen receptor modulators 60 FGFs 60 refractory indolent non 60 Vicriviroc 60 Trichomonas vaginalis 60 relapsed ALL 60 PDE4 60 HuCAL PLATINUM ® CysDisplay 60 recurrent genital herpes 60 malignant lymphomas 60 underlying vasculopathy 60 cisplatin carboplatin 60 reverse transcriptase inhibitor 60 Acute Bacterial Sinusitis ABS 60 TLR8 60 oncogenic HPV 60 Chemophase 60 Nanobody ® 60 TRV# [001] 60 pediatric acute lymphoblastic 60 substrates inhibitors 60 ENMD # 60 IRX 2 60 nucleotide analog 60 cortisol synthesis 60 breast pancreatic 60 Myocet 60 MEK ERK 60 PNT# 60 basiliximab 60 histone methyltransferases HMTs 60 chronic immune thrombocytopenic 60 radionuclide therapy 60 tumor vascular disrupting 60 Liprotamase 60 Epidermal Growth Factor 60 chemokine receptors 60 tumor subtypes 60 leukotriene receptor antagonist 60 LNP formulations 60 corticosteroid dexamethasone 60 Selzentry Celsentri 60 naloxol derivative 60 KRAS oncogene 60 interferon alpha IFN 60 Intravenous CP 60 peptide antigens 60 HDACi 60 Associated Diarrhea 60 IgG1 antibody 60 Luteinizing Hormone Releasing Hormone 60 Janus Kinase 60 HER2 HER3 60 azoles 60 anticancer agents 60 penicillins cephalosporins 60 PDE4 inhibitor 60 mertansine 60 DGAT 60 Campath ® 60 Ustekinumab 60 mu opioid receptor antagonist 60 secondary amenorrhea 60 3TC lamivudine 60 hepatitis B HBV 60 prostate cancer antigen prostatic 60 therapeutic monoclonal antibody 60 CD8 + cytotoxic 60 diabetic kidney 60 Dalbavancin 60 antiretroviral naïve 60 Basal cell 60 prostate cancer CaP 60 RhuDex ™ 60 Rigel R# 60 lung fibrosis 60 Myelodysplastic Syndrome MDS 60 Stapled Peptide 60 Modrenal 60 5 HT2A inverse 60 CDK cyclin dependent 60 chemosensitizer 60 non porcine pancreatic 60 Alequel